NCT00735410View on ClinicalTrials.gov

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

PHASE3CompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Seasonal Influenza, Vaccine

Interventions

BIOLOGICAL

Seasonal Influenza Vaccine

1 dose of Split influenza vaccine

Trial Locations (1)

35033

Site 1, 2 and 3, Hessen

Sponsors

Lead Sponsor

Novartis Vaccines

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY